Keywords: Teva, Nuvigil, Patent, Mylan, Doryx, Warner Chilcott, Wakefulness, Antibiotic, M&S talks

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

Article | 01 May 2012

Print This

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s largest generics companies, said yesterday that it has settled patent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in